Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Reassessment of venous thromboembolism and bleeding risk in medical patients receiving VTE prophylaxis.

Tung EC, Yu SY, Shah K, Kinkade A, Tejani AM.

J Eval Clin Pract. 2019 Jul 7. doi: 10.1111/jep.13213. [Epub ahead of print]

PMID:
31282101
2.

Pharmacotherapy for hypertension in adults 60 years or older.

Musini VM, Tejani AM, Bassett K, Puil L, Wright JM.

Cochrane Database Syst Rev. 2019 Jun 5;6:CD000028. doi: 10.1002/14651858.CD000028.pub3.

PMID:
31167038
3.

Guidelines Versus Guidelines.

O'Sullivan C, Tejani AM, Finucane T.

Ann Intern Med. 2018 Dec 18;169(12):895-896. doi: 10.7326/L18-0559. No abstract available.

PMID:
30557432
4.

Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015.

Hong J, Tung A, Kinkade A, Tejani AM.

J Clin Epidemiol. 2019 Apr;108:144-146. doi: 10.1016/j.jclinepi.2018.11.028. Epub 2018 Dec 6. No abstract available.

PMID:
30529004
5.

Is There a Reason for the Proton Pump Inhibitor? An Assessment of Prescribing for Residential Care Patients in British Columbia.

Chan A, Liang L, Tung ACH, Kinkade A, Tejani AM.

Can J Hosp Pharm. 2018 Sep-Oct;71(5):295-301. Epub 2018 Oct 31.

6.

Are antidepressant and antipsychotic drug trials registered? A cross-sectional analysis of registration and reporting of methodologic characteristics.

Shaw R, Ni M, Pillar M, Tejani AM.

Account Res. 2018;25(5):301-309. doi: 10.1080/08989621.2018.1486191. Epub 2018 Jun 25.

PMID:
29879851
7.

Going through the Motions: A Time-and-Motion Study of Workload Associated with Nonformulary Medication Orders.

Chang E, Kinkade A, Tung ACH, Tejani AM.

Can J Hosp Pharm. 2017 Mar-Apr;70(2):133-137. Epub 2017 Apr 28. No abstract available.

8.

5α-Reductase Inhibitors for Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.

Jun JEJ, Kinkade A, Tung ACH, Tejani AM.

Can J Hosp Pharm. 2017 Mar-Apr;70(2):113-119. Epub 2017 Apr 28. Review.

9.

Re: Fei Y, Guyatt GH, Alexander PE, et al. Addition of ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient-important outcomes. J Eval Clin Pract.

O'Sullivan CSE, Tejani AM.

J Eval Clin Pract. 2018 Feb;24(1):264-265. doi: 10.1111/jep.12755. Epub 2017 Apr 7. No abstract available.

PMID:
28387459
10.

Eplerenone for hypertension.

Tam TS, Wu MH, Masson SC, Tsang MP, Stabler SN, Kinkade A, Tung A, Tejani AM.

Cochrane Database Syst Rev. 2017 Feb 28;2:CD008996. doi: 10.1002/14651858.CD008996.pub2. Review.

11.

Identification of Patients Eligible for IV-to-PO Conversion: A Cost-Minimization Study.

Mok M, Kinkade A, Tung A, Tejani AM.

Can J Hosp Pharm. 2016 Jul-Aug;69(4):301-5. Epub 2016 Aug 31. No abstract available.

12.

Tinzaparin vs Warfarin for Acute Venous Thromboembolism.

Maruyama A, Tejani AM, Perry TL.

JAMA. 2016 Jan 12;315(2):200. doi: 10.1001/jama.2015.15067. No abstract available.

PMID:
26757471
13.

Probiotics for preventing urinary tract infections in adults and children.

Schwenger EM, Tejani AM, Loewen PS.

Cochrane Database Syst Rev. 2015 Dec 23;(12):CD008772. doi: 10.1002/14651858.CD008772.pub2. Review.

PMID:
26695595
14.
15.

Ten Commandments for patient-centred treatment.

Lehman R, Tejani AM, McCormack J, Perry T, Yudkin JS.

Br J Gen Pract. 2015 Oct;65(639):532-3. doi: 10.3399/bjgp15X687001. No abstract available.

16.

Managing the incidence of selective reporting bias: a survey of Cochrane review groups.

Reid EK, Tejani AM, Huan LN, Egan G, O'Sullivan C, Mayhew AD, Kabir M.

Syst Rev. 2015 Jun 13;4:85. doi: 10.1186/s13643-015-0070-y. Review.

17.

New oral anticoagulants.

Perry TL, Wright JM, Mintzes B, O'Sullivan C, Tejani AM.

CMAJ. 2015 May 19;187(8):603. doi: 10.1503/cmaj.1150037. No abstract available.

18.

Effectiveness and Safety of a High-Dose (20,000 IU) Weekly Vitamin D Protocol in Older Adults in Residential Care.

Tkachuk S, Rahmatian D, Burgess S, Froyman C, O'Sullivan C, Tejani AM.

J Am Geriatr Soc. 2015 Apr;63(4):834-5. doi: 10.1111/jgs.13354. No abstract available.

PMID:
25900508
19.

Loop diuretics for patients receiving blood transfusions.

Sarai M, Tejani AM.

Cochrane Database Syst Rev. 2015 Feb 16;(2):CD010138. doi: 10.1002/14651858.CD010138.pub2. Review.

20.

Biomedical journals lack a consistent method to detect outcome reporting bias: a cross-sectional analysis.

Huan LN, Tejani AM, Egan G.

J Clin Pharm Ther. 2014 Oct;39(5):501-6. doi: 10.1111/jcpt.12172. Epub 2014 May 14.

PMID:
24828874
21.

Not quite the full story on new antiplatelets.

O'Sullivan C, Tejani AM.

CMAJ. 2014 Apr 15;186(7):533. doi: 10.1503/cmaj.114-0027. No abstract available.

22.

Eculizumab in atypical hemolytic-uremic syndrome.

Amadio A, Tejani AM.

N Engl J Med. 2013 Oct 3;369(14):1378. doi: 10.1056/NEJMc1308826. No abstract available.

PMID:
24088107
23.

Magnesium for alcohol withdrawal.

Sarai M, Tejani AM, Chan AH, Kuo IF, Li J.

Cochrane Database Syst Rev. 2013 Jun 5;(6):CD008358. doi: 10.1002/14651858.CD008358.pub2. Review.

PMID:
23740536
24.

Minimum clinically important differences identified for commonly used depression rating scales.

Masson SC, Tejani AM.

J Clin Epidemiol. 2013 Jul;66(7):805-7. doi: 10.1016/j.jclinepi.2013.01.010. Epub 2013 Apr 22. No abstract available.

PMID:
23618794
25.

Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections.

Shiu J, Wang E, Tejani AM, Wasdell M.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD008481. doi: 10.1002/14651858.CD008481.pub2. Review.

PMID:
23543565
26.

Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis.

Fortin PM, Tejani AM, Bassett K, Musini VM.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD007057. doi: 10.1002/14651858.CD007057.pub3. Review.

PMID:
23440811
27.

Risk-benefit profile of inhaled corticosteroids in COPD is still unclear.

Turgeon RD, Tejani AM.

BMJ. 2012 Dec 20;345:e8360; author reply e8375. doi: 10.1136/bmj.e8360. No abstract available.

PMID:
23257650
28.
29.

Raise the bar even higher for primary prevention interventions.

Wright JM, Bassett KL, Tejani AM.

Arch Intern Med. 2012 Sep 24;172(17):1352-3 author reply 1353. No abstract available.

PMID:
23007457
30.

Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients.

Stabler SN, Tejani AM, Huynh F, Fowkes C.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007653. doi: 10.1002/14651858.CD007653.pub2. Review.

PMID:
22895963
31.

Another hypertension visit.

Tejani AM, Siu JT, Wright JM, Bassett K, Musini V, Mintzes B, Perry T.

Can Fam Physician. 2012 Aug;58(8):829-30. No abstract available.

32.

Carnitine for fatigue in multiple sclerosis.

Tejani AM, Wasdell M, Spiwak R, Rowell G, Nathwani S.

Cochrane Database Syst Rev. 2012 May 16;(5):CD007280. doi: 10.1002/14651858.CD007280.pub3. Review.

33.

No better than less expensive drugs.

Perry TL, Lippman SS, McConnell M, Tejani AM.

BMJ. 2012 Apr 24;344:e2914. doi: 10.1136/bmj.e2914. No abstract available.

PMID:
22531805
34.

Statins for primary prevention.

Tejani AM, Musini V, Bassett K, Dormuth C, Perry T, Wright JM.

CMAJ. 2012 Apr 17;184(7):791; author reply 791-2. doi: 10.1503/cmaj.112-2036. No abstract available.

35.

Current-oasis: a potential mirage of numbers.

Magnusson T, Tejani AM.

Can J Hosp Pharm. 2011 Mar;64(2):155-6. No abstract available.

36.

Not quite a breath of fresh air: use of combination inhalers in COPD.

Stabler S, Tejani AM, Bruchet N.

Can Fam Physician. 2012 Feb;58(2):149-50. No abstract available.

37.

Hypertension control in patients with diabetes.

Siu JT, Tejani AM, Musini V, Bassett K, Mintzes B, Wright J.

Can Fam Physician. 2012 Jan;58(1):31-3. No abstract available.

38.

Hydralazine for essential hypertension.

Kandler MR, Mah GT, Tejani AM, Stabler SN, Salzwedel DM.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD004934. doi: 10.1002/14651858.CD004934.pub4. Review.

PMID:
22071816
39.

Osteoporosis guidelines miss big picture.

Tejani AM.

CMAJ. 2011 Apr 5;183(6):695-6. doi: 10.1503/cmaj.111-2032. No abstract available.

40.

Comment on dexmedetomidine systematic review and meta-analysis methodology.

Tejani AM, Schwenger E.

Intensive Care Med. 2010 Nov;36(11):1974; author reply 1975. doi: 10.1007/s00134-010-2010-6. Epub 2010 Aug 6. No abstract available.

PMID:
20689913
41.

Spironolactone for hypertension.

Batterink J, Stabler SN, Tejani AM, Fowkes CT.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD008169. doi: 10.1002/14651858.CD008169.pub2. Review.

PMID:
20687095
42.

Hydralazine for essential hypertension.

Kandler MR, Mah GT, Tejani AM, Stabler SN.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD004934. doi: 10.1002/14651858.CD004934.pub3. Review. Update in: Cochrane Database Syst Rev. 2011;(11):CD004934.

PMID:
20687078
43.

Carnitine for fatigue in multiple sclerosis.

Tejani AM, Wasdell M, Spiwak R, Rowell G, Nathwani S.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD007280. doi: 10.1002/14651858.CD007280.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;5:CD007280.

PMID:
20166093
44.

Methyldopa for primary hypertension.

Mah GT, Tejani AM, Musini VM.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD003893. doi: 10.1002/14651858.CD003893.pub3. Review.

PMID:
19821316
45.

Pharmacotherapy for hypertension in the elderly.

Musini VM, Tejani AM, Bassett K, Wright JM.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD000028. doi: 10.1002/14651858.CD000028.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Jun 05;6:CD000028.

PMID:
19821263
46.

Systematic review of evidence for the use of intradialytic parenteral nutrition in malnourished hemodialysis patients.

Sigrist MK, Levin A, Tejani AM.

J Ren Nutr. 2010 Jan;20(1):1-7. doi: 10.1053/j.jrn.2009.08.003. Epub 2009 Sep 27. Review.

PMID:
19788956
47.

Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis.

Fortin PM, Tejani AM, Bassett K, Musini VM.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007057. doi: 10.1002/14651858.CD007057.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD007057.

PMID:
19588418
48.

Dronedarone in atrial fibrillation.

Tejani AM, Yih V.

N Engl J Med. 2009 Jun 4;360(23):2479; author reply 2480-1. doi: 10.1056/NEJMc090521. No abstract available.

PMID:
19494229
50.

Comment: Thiazolidinediones in type 2 diabetes: a cardiology perspective.

Musini VM, Bassett KL, Tejani AM.

Ann Pharmacother. 2009 Feb;43(2):391-2; author reply 392-3. doi: 10.1345/aph.1K666a. No abstract available.

PMID:
19193598

Supplemental Content

Loading ...
Support Center